Safety Rates Drug Report: LEVOFLOXACINE MYLAN//LEVOFLOXACIN HEMIHYDRATE Blood bilirubin increased adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

2004.Q1 2004.Q2 2004.Q3 2004.Q4 2005.Q1 2005.Q2 2005.Q3 2005.Q4 2006.Q1 2006.Q2 2006.Q3 2006.Q4 2007.Q1 2007.Q2 2007.Q3 2007.Q4 2008.Q1 2008.Q2 2008.Q3 2008.Q4 2009.Q1 2009.Q2 2009.Q3 2009.Q4 2010.Q1 2010.Q2 2010.Q3 2010.Q4 2011.Q1 2011.Q2 2011.Q3 2011.Q4 2012.Q1 2012.Q2 2012.Q3 2012.Q4 2013.Q1 2013.Q2 2013.Q3 2013.Q4 2014.Q1 2014.Q2 2014.Q3 2014.Q4 2015.Q1 2015.Q2 2015.Q3 2015.Q4 2016.Q1 2016.Q2 2016.Q3

Drug Injury Quarter

Drug: LEVOFLOXACINE MYLAN//LEVOFLOXACIN HEMIHYDRATE Injury: Blood bilirubin increased Quarter: 2016Q3

|< 1/2 << Previous Page Page 1

Total Records: 1 Number of Pages: 1

Event ID	DRUGNAME	PT	Drug Manufacturer	Patient Age	Sex	Weight	Date (YYYYMMDD)	Country
126852643	LEVOFLOXACINE MYLAN//LEVOFLOXACIN HEMIHYDRATE	Blood bilirubin increased	SANDOZ	77.00 YR	M	0	20160912	FR

|< 1/2 << Previous Page Page 1

Total Records: 1 Number of Pages: 1

Execution Time: 0.0065150260925293 seconds (ucode:5219354). Developed by: James D. Barger